Wall Street Associates’s CareDx CDNA Stock Holding History

Wall Street Associates’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-38,811	Closed	-$272K	–	323
2014 Q3	$272K	Buy	+38,811	New	+$373K	0.03%	311

Other funds holding CDNA

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wall Street Associates's CDNA Position: Q4 2014 in Review

Wall Street Associates sold out of CareDx (CDNA) in Q4 2014, closing a stake of 38,811 shares — an estimated $272K sold.

Wall Street Associates first reported a position in CDNA in Q3 2014 and held it in 1 quarter. The position peaked at $272K in Q3 2014. 19 funds tracked by Wall St. Rank hold CDNA as of Q4 2014.

Wall Street Associates reported no remaining CareDx position as of Q4 2014 after selling out during the quarter.
Wall Street Associates sold 38,811 CareDx shares in Q4 2014, an estimated $272K.
Wall Street Associates first reported a position in CareDx in Q3 2014 and held it in 1 quarter.
Wall Street Associates's CareDx position peaked at $272K in Q3 2014.
19 funds tracked by Wall St. Rank held CareDx as of Q4 2014.

Based on Wall Street Associates's 13F filing for Q4 2014, filed 12 Feb 2015.